lercanidipine

Known as: methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 
 

Topic mentions per year

Topic mentions per year

1996-2018
010203019962018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The objective of this study was to develop lercanidipine-hydroxypropylmethyl cellulose (HPMC) nanoparticles with high oral… (More)
Is this relevant?
2007
2007
The purpose of this research was to develop and evaluate buccal mucoadhesive controlled release tablets of lercanidipine… (More)
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
2006
2006
Increased levels of metalloproteinase (MMP)-9 have been shown in hypertensive patients. Lercanidipine is a calcium channel… (More)
Is this relevant?
2005
2005
Intracerebroventricular (ICV) injection of streptozotocin (STZ) causes cognitive impairment in rats. ICV STZ is known to impair… (More)
Is this relevant?
2005
2005
OBJECTIVE The objective was primary to evaluate the safe use of a new calcium channel blocker, lercanidipine, in patients with… (More)
  • table 2
  • figure 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
2003
2003
The objective of this 8-week open-label study was to compare the tolerability of lercanidipine, a dihydropyridine calcium-channel… (More)
Is this relevant?
2003
2003
OBJECTIVE Of the study was to compare the leg oedema-forming potential of two different dihydropyridine calcium channel blockers… (More)
Is this relevant?
2003
2003
Essential hypertension is associated with impaired endothelium-dependent vasodilation caused by oxidative stress-induced nitric… (More)
  • figure 1
  • figure 2
Is this relevant?
2003
2003
An HPLC reversed phase method using both UV (356 nm) and electrochemical (1000 mV) detection was developed in order to determine… (More)
Is this relevant?
2002
2002
BACKGROUND Irrespective of their clinical relevance, side effects cannot be considered a negligible problem in antihypertensive… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 4
Is this relevant?